REGN10597
/ Regeneron
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 15, 2024
A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies
(clinicaltrials.gov)
- P1/2 | N=150 | Recruiting | Sponsor: Regeneron Pharmaceuticals | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Clear Cell Renal Cell Carcinoma • Genito-urinary Cancer • Melanoma • Oncology • Renal Cell Carcinoma • Solid Tumor
May 14, 2024
A First-In Human (FIH) Trial to Find Out if REGN10579 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies
(clinicaltrials.gov)
- P1/2 | N=150 | Not yet recruiting | Sponsor: Regeneron Pharmaceuticals
Metastases • New P1/2 trial • Clear Cell Renal Cell Carcinoma • Genito-urinary Cancer • Melanoma • Oncology • Renal Cell Carcinoma • Solid Tumor
1 to 2
Of
2
Go to page
1